Yasmin Thanavala

Dr. Yasmin Thanavala

Roswell Park Cancer Institute, Department of Immunology, Buffalo, NY, USA
orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2005 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
YTYasmin Thanavala
Yasmin Thanavala
MMMartin Mahoney
Martin Mahoney
SPSribani Pal
Sribani Pal
ASAdrienne Scott
Adrienne Scott
LRLiz Richter
Liz Richter
HMHugh S. Mason
Hugh S. Mason
A double-blind placebo-controlled clinical trial evaluated the immunogenicity of hepatitis B surface antigen (HBsAg) expressed in potatoes and delivered orally to previously vaccinated individuals. The potatoes accumulated HBsAg at ≈8.5 μg/g of potato tuber, and doses of 100 g of tuber were administered by ingestion. The correlate of protection for hepatitis B virus, a nonenteric pathogen, is blood serum antibody titers against HBsAg. After volunteers ate uncooked potatoes, serum anti-HBsAg titers increased in 10 of 16 volunteers (62.5%) who ate three doses of potatoes; in 9 of 17 volunteers (52.9%) who ate two doses of transgenic potatoes; and in none of the volunteers who ate nontransgenic potatoes. These results were achieved without the coadministration of a mucosal adjuvant or the need for buffering stomach pH. We conclude that a plant-derived orally delivered vaccine for prevention of hepatitis B virus should be considered as a viable component of a global immunization program.

15 April 2013 in Cancer Research
Verified
Journal Article
Closed access
PDF file
SKSuresh Kalathil
Suresh Kalathil
ALAmit A. Lugade
Amit A. Lugade
AMAustin Miller
Austin Miller
Renuka IyerRenuka Iyer
Renuka Iyer
YTYasmin Thanavala
Yasmin Thanavala
The extent to which T-cell–mediated immune surveillance is impaired in human cancer remains a question of major importance, given its potential impact on the development of generalized treatments of advanced disease where the highest degree of heterogeneity exists. Here, we report the first global analysis of immune dysfunction in patients with advanced hepatocellular carcinoma (HCC). Using multi-parameter fluorescence-activated cell sorting analysis, we quantified the cumulative frequency of regulatory T cells (Treg), exhausted CD4+ helper T cells, and myeloid-derived suppressor cells (MDSC) to gain concurrent views on the overall level of immune dysfunction in these inoperable patients. We documented augmented numbers of Tregs, MDSC, PD-1+–exhausted T cells, and increased levels of immunosuppressive cytokines in patients with HCC, compared with normal controls, revealing a network of potential mechanisms of immune dysregulation in patients with HCC. In dampening T-cell–mediated antitumor immunity, we hypothesized that these processes may facilitate HCC progression and thwart the efficacy of immunotherapeutic interventions. In testing this hypothesis, we showed that combined regimens to deplete Tregs, MDSC, and PD-1+ T cells in patients with advanced HCC restored production of granzyme B by CD8+ T cells, reaching levels observed in normal controls and also modestly increased the number of IFN-γ producing CD4+ T cells. These clinical findings encourage efforts to restore T-cell function in patients with advanced stage disease by highlighting combined approaches to deplete endogenous suppressor cell populations that can also expand effector T-cell populations. Cancer Res; 73(8); 2435–44. ©2013 AACR.

1 November 2015 in Annals of the American Thoracic Society
Verified
Journal Article
Closed access
TBTariq A. Bhat
Tariq A. Bhat
LPLouis Panzica
Louis Panzica
SKSuresh Gopi Kalathil
Suresh Gopi Kalathil
YTYasmin Thanavala
Yasmin Thanavala
Chronic obstructive pulmonary disease (COPD) is a complex chronic disease. Chronic inflammation is the hallmark of COPD, involving the interplay of a wide variety of cells in the lung microenvironm...

26 February 2020 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
TBTariq A. Bhat
Tariq A. Bhat
SKSuresh G. Kalathil
Suresh G. Kalathil
PBPaul N. Bogner
Paul N. Bogner
BBBenjamin C. Blount
Benjamin C. Blount
MGMaciej Goniewicz
Maciej Goniewicz
YTYasmin Thanavala
Yasmin Thanavala
As of February 4, 2020, electronic-cigarette, or vaping, product use–associated lung injury (EVALI) has resulted in the hospitalization of 2758 people across the United States and has been linked to at least 64 deaths (www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html). Although recent testing by the Centers for Disease Control and Prevention showed the presence of vitamin E acetate in bronchoalveolar-lavage (BAL) fluid samples obtained from patients with EVALI,1,2 additional studies are necessary to determine whether a causal link exists between inhalation of vitamin E acetate and EVALI.

1 July 2014 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
SKSuresh Gopi Kalathil
Suresh Gopi Kalathil
ALAmit Anand Lugade
Amit Anand Lugade
VPVandana Pradhan
Vandana Pradhan
AMAustin Miller
Austin Miller
GPGanapathi Iyer Parameswaran
Ganapathi Iyer Parameswaran
YTYasmin Thanavala
Yasmin Thanavala
Rationale: Previous studies from our laboratory have shown that peripheral blood mononuclear cells (PBMCs) from patients with chronic obstructive pulmonary disease (COPD) prone to exacerbations with nontypeable Haemophilus influenzae have impaired responses to lipoprotein P6. We hypothesized that an underlying immunosuppressive network could be responsible for the defective antibacterial immunity observed in these patients. We evaluated T regulatory cells (Tregs), myeloid-derived suppressor cells (MDSC), and exhausted T effector cells (programmed death 1 [PD-1]+) in patients with COPD, because these cells are known to play a pivotal role in suppressing immune responses. Objectives: We performed an in-depth characterization of Tregs, T effector cells, and MDSC in COPD and correlated their levels and function with disease severity. Methods: Treg, effector T cell, and MDSC frequency from patients with COPD and healthy subjects’ PBMCs were analyzed by flow cytometry. Treg immunosuppressive capacity was measured by in vitro suppression assay. The frequency of interferon-γ producing T cells and T-cell proliferation were measured after blocking CTLA-4 and PD-1. Plasma proinflammatory and immunosuppressive cytokine levels were measured. Measurements and Main Results: Significantly increased levels of Tregs, MDSC, and PD-1+ exhausted effector T cells were present in patients with COPD compared with healthy subjects. Tregs from patients with COPD suppressed P6-specific T-cell proliferation to a greater extent than Tregs from healthy subjects. Plasma levels of Treg-generated cytokines, IL-10, and transforming growth factor-β were elevated. Blockade of CTLA-4 resulted in significant augmentation of T-cell IFN-γ production in patients with COPD. Conclusions: Functionally suppressive Tregs, MDSCs, and exhausted PD-1+ T cells contribute to effector T-cell dysfunction in COPD.

1 June 2014 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
ALAmit A Lugade
Amit A Lugade
PBPaul N. Bogner
Paul N. Bogner
TTThomas H. Thatcher
Thomas H. Thatcher
PSPatricia J. Sime
Patricia J. Sime
RPRichard P. Phipps
Richard P. Phipps
YTYasmin Thanavala
Yasmin Thanavala
The detrimental impact of tobacco on human health is clearly recognized, and despite aggressive efforts to prevent smoking, close to one billion individuals worldwide continue to smoke. People with chronic obstructive pulmonary disease are susceptible to recurrent respiratory infections with pathogens, including nontypeable Haemophilus influenzae (NTHI), yet the reasons for this increased susceptibility are poorly understood. Because mortality rapidly increases with multiple exacerbations, development of protective immunity is critical to improving patient survival. Acute NTHI infection has been studied in the context of cigarette smoke exposure, but this is the first study, to our knowledge, to investigate chronic infection and the generation of adaptive immune responses to NTHI after chronic smoke exposure. After chronic NTHI infection, mice that had previously been exposed to cigarette smoke developed increased lung inflammation and compromised adaptive immunity relative to air-exposed controls. Importantly, NTHI-specific T cells from mice exposed to cigarette smoke produced lower levels of IFN-γ and IL-4, and B cells produced reduced levels of Abs against outer-membrane lipoprotein P6, with impaired IgG1, IgG2a, and IgA class switching. However, production of IL-17, which is associated with neutrophilic inflammation, was enhanced. Interestingly, cigarette smoke–exposed mice exhibited a similar defect in the generation of adaptive immunity after immunization with P6. Our study has conclusively demonstrated that cigarette smoke exposure has a profound suppressive effect on the generation of adaptive immune responses to NTHI and suggests the mechanism by which prior cigarette smoke exposure predisposes chronic obstructive pulmonary disease patients to recurrent infections, leading to exacerbations and contributing to mortality.